Grayhawk Investment Strategies’s Gilead Sciences GILD Stock Holding History

Grayhawk Investment Strategies’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$12.4K	Hold	111	–	–	0.03%	84
2024 Q4	$10.3K	Hold	111	–	–	0.02%	90
2024 Q3	$9.31K	Hold	111	–	–	0.01%	77
2024 Q2	$7.62K	Hold	111	–	–	0.03%	104
2024 Q1	$8.13K	Hold	111	–	–	0.01%	133
2023 Q4	$8.99K	Hold	111	–	–	﹤0.01%	213
2023 Q3	$8.32K	Hold	111	–	–	0.01%	115
2023 Q2	$8.55K	Hold	111	–	–	0.01%	117
2023 Q1	$12K	Hold	111	–	–	0.01%	116
2022 Q4	$9.53K	Hold	111	–	–	0.01%	100
2022 Q3	$9K	Hold	111	–	–	0.01%	127
2022 Q2	$9K	Buy	+111	New	+$6.87K	﹤0.01%	129

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Grayhawk Investment Strategies's GILD Position: Q1 2025 in Review

Grayhawk Investment Strategies held its Gilead Sciences (GILD) position steady in Q1 2025 at 111 shares worth $12.4K. The position accounts for 0.03% of the portfolio, ranked #84.

Grayhawk Investment Strategies first reported a position in GILD in Q2 2022 and has held it in 12 quarters since. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Grayhawk Investment Strategies held 111 shares of Gilead Sciences worth $12.4K as of Q1 2025.
Grayhawk Investment Strategies left its Gilead Sciences share count unchanged in Q1 2025.
Gilead Sciences made up 0.03% of Grayhawk Investment Strategies's portfolio in Q1 2025, its #84 holding.
Grayhawk Investment Strategies first reported a position in Gilead Sciences in Q2 2022 and has held it in 12 quarters since.
2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Grayhawk Investment Strategies's 13F filing for Q1 2025, filed 15 May 2025.